January 31, 2023 · STOCK Act disclosure
Representative Daniel S. Goldman (Democrat-NY) sold Arrowhead Pharmaceuticals, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on January 31, 2023 and was disclosed on February 24, 2023 (owner: DC). Members of Congress must report such transactions within 45 days under the STOCK Act.